Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Typhonium flagelliforme
Small tropical herb native to Southeast Asia used in Malaysian and Indonesian traditional medicine and researched for anticancer properties.
Typhonium flagelliforme is a small tropical herb from Southeast Asia, traditionally used in Malaysian and Indonesian medicine for cancer support, inflammation, and liver conditions. Modern research, though limited (Evidence Level C), suggests potential anticancer, immunomodulatory, and anti-inflammatory activities attributed to ribosome-inactivating proteins, flavonoids, alkaloids, and tannins.
The herb's ribosome-inactivating proteins (RIPs) may inhibit protein synthesis in malignant cells, while flavonoids and alkaloids modulate inflammatory pathways such as NF-κB and COX-2. Immunomodulatory effects are thought to involve stimulation of macrophage activity and cytokine release (e.g., TNF-α, IL-2). These mechanisms collectively contribute to its traditional and investigational anticancer and anti-inflammatory roles.
Small tropical herb native to Southeast Asia used in Malaysian and Indonesian traditional medicine and researched for anticancer properties.
Typhonium flagelliforme is a small tropical herb from Southeast Asia, traditionally used in Malaysian and Indonesian medicine for cancer support, inflammation, and liver conditions. Modern research, though limited (Evidence Level C), suggests potential anticancer, immunomodulatory, and anti-inflammatory activities attributed to ribosome-inactivating proteins, flavonoids, alkaloids, and tannins.
The herb's ribosome-inactivating proteins (RIPs) may inhibit protein synthesis in malignant cells, while flavonoids and alkaloids modulate inflammatory pathways such as NF-κB and COX-2. Immunomodulatory effects are thought to involve stimulation of macrophage activity and cytokine release (e.g., TNF-α, IL-2). These mechanisms collectively contribute to its traditional and investigational anticancer and anti-inflammatory roles.